Report: Health exchanges' drug coverage confusing
By CARLA K. JOHNSON - AP - 1 min ago
CHICAGO (AP) — The hunt for a health plan that would cover a particular drug or a favorite doctor proved particularly frustrating for many consumers navigating the new insurance exchanges under the federal government's health care overhaul, according to a report released Monday.
'Fast Money' Recap: The Problem With Growth Stocks
at The Street - 2 hrs 4 mins ago
The trading panel wonders why Facebook is having a good quarter when Google has been selling off.
Asia markets mixed, Australia touches 6-year high
The Associated Press - AP - Mon Apr 28, 10:42PM CDT
HONG KONG (AP) — Asian stocks were mixed Tuesday, with Australia's benchmark briefly touching a six-year high while other markets lacked a clear focus as investors stayed on the sidelines ahead of a number of economic data reports later this week.
2 Comments
Dow Climbs 87 As Bank of America and Pfizer Dominate Headlines
Jack Kramer and Nick Martell, The Motley Fool - Motley Fool - Mon Apr 28, 10:00PM CDT
We know. Your schedule is packed this week with NHL playoff games and early spring BBQ shenanigans. Now add to your list the two-day Federal Reserve policy meeting, a whole bunch of headline earnings reports, and Friday's big April jobs report....
Pfizer Could Buy These 30 Biotechs Instead of One AstraZeneca (but It Won't)
Brian Orelli, The Motley Fool - Motley Fool - Mon Apr 28, 6:26PM CDT
The rumors are true. Pfizer offered to buy AstraZeneca for $76.62 per share, valuing the company around $100 billion. A hundred billion! To put that in perspective, instead of buying AstraZeneca, Pfizer could buy these 30 biotech...
China Rule Change Further Opens Yuan To World Markets
at Investor's Business Daily - Mon Apr 28, 5:31PM CDT
Big purses started spilling open around the globe in the past week. GlaxoSmithKline (GSK), Novartis (NVS) and Eli Lilly (LLY) announced a series of business swaps valued at $19.9 billion. AstraZeneca (AZN) straight-armed a $98 billion offer from...
Merck & Co., Inc. Earnings: Is Growth Around the Corner?
Dan Caplinger, The Motley Fool - Motley Fool - Mon Apr 28, 5:30PM CDT
On Tuesday, Merck will release its quarterly report, and investors have sent the stock soaring to multiyear highs recently. Even though Merck's revenue and earnings aren't likely to grow from year-ago levels, Merck is showing promise in its...
Most active New York Stock Exchange-traded stocks
AP - Mon Apr 28, 5:13PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Mon Apr 28, 5:13PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Bank of America, AstraZeneca are big market movers
AP - Mon Apr 28, 4:52PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
Business Highlights
By The Associated Press - AP - Mon Apr 28, 4:38PM CDT
___
Stocks higher on deal hopes; BofA sinks
By KEN SWEET - AP - Mon Apr 28, 4:17PM CDT
NEW YORK (AP) — It was a choppy ride for the stock market on Monday that ended with major U.S. indexes closing mostly higher.
Why Susser Holdings, Furiex Pharmaceuticals, and AstraZeneca Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Mon Apr 28, 4:15PM CDT
Another "Merger Monday" lit a fire beneath investors and the S&P 500 with merger and acquisition rumblings and announcements signaling to investors that businesses are still willing to take on risks in order to expand. The end result was yet...
How the Dow Jones industrial average did Monday
The Associated Press - AP - Mon Apr 28, 4:08PM CDT
It was a choppy day on the stock market on Monday that ended with major U.S. indexes closing mostly higher.
Why Merck Will Move the Dow Tomorrow
Dan Caplinger, The Motley Fool - Motley Fool - Mon Apr 28, 3:30PM CDT
The Dow Jones Industrials climbed 87 points on Monday, as investors were relieved not to have seen some of their immediate geopolitical fears pan out over the weekend. Part of the excitement in today's market action came from Dow component Pfizer...
Nasdaq Recovers After Early Weakness; Apple Rallies Again
at Investor's Business Daily - Mon Apr 28, 3:28PM CDT
The Dow Jones industrial average and S&P 500 ended higher Monday, and the Nasdaq recovered early losses in a resilient performance. At the close, the Nasdaq fell less than 0.1% lower after being down by as much as 1.5%. It's still holding above its...
Why Pfizer (PFE) and AstraZeneca (AZN) Stocks Are Up Today
at The Street - Mon Apr 28, 3:26PM CDT
Pfizer (PFE) and AstraZeneca (AZN) rose Monday amid more takeover talks between the two pharmaceutical companies.
U.S. Stocks Mount Midday Turnaround to Close Higher, Bank of America Plunges
at The Street - Mon Apr 28, 3:19PM CDT
U.S. stocks turned around earlier losses Monday and closed in the green, while shares of banking giant Bank of America plunge on a capital blunder.
Late push leaves US stock market mostly higher
AP - Mon Apr 28, 3:14PM CDT
NEW YORK (AP) — Stocks are ending a choppy day mostly higher as investors balanced enthusiasm over a possible merger in the health care industry with bad news from Bank of America.
Pfizer still pursuing AstraZeneca after 2nd rebuff
By DANICA KIRKA and LINDA A. JOHNSON - AP - Mon Apr 28, 4:10PM CDT
LONDON (AP) — Pfizer Inc. was turned down twice by fellow drugmaker AstraZeneca PLC, but the maker of Viagra and Lipitor said Monday that its proposed $100 billion acquisition makes sense for shareholders of both companies, and it's considering its next steps.